FDA Withdraws Approval for Roxarsone and Carbarsone Animal Drug Applications

Summary

The US Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the withdrawal of approval for three new animal drug applications (NADAs) for roxarsone or carbarsone, following a sponsor's request, as the products are no longer in production or distribution.